Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 136.75
-1.50 (-1.08%)
At close: Feb 13, 2026
Beijing Hotgen Biotech Market Cap
Beijing Hotgen Biotech has a market cap or net worth of 12.15 billion as of February 13, 2026. Its market cap has increased by 101.20% in one year.
Market Cap
12.15B
Enterprise Value
11.10B
Revenue
434.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
136.75
Market Cap Chart
Since September 30, 2019, Beijing Hotgen Biotech's market cap has increased from 4.41B to 12.15B, an increase of 175.52%. That is a compound annual growth rate of 17.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 12.15B | -15.59% |
| Dec 31, 2025 | 14.39B | 159.78% |
| Dec 31, 2024 | 5.54B | 50.94% |
| Dec 29, 2023 | 3.67B | -34.53% |
| Dec 30, 2022 | 5.61B | -22.40% |
| Dec 31, 2021 | 7.22B | 197.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacific Shuanglin Bio-pharmacy | 12.82B |
| InventisBio | 12.73B |
| Hualan Biological Vaccine | 12.48B |
| Staidson (Beijing) BioPharmaceuticals | 12.46B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 11.83B |
| HitGen | 11.76B |
| Vcanbio Cell & Gene Engineering Corp., | 11.40B |
| Chengdu Easton Biopharmaceuticals | 11.23B |